Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021

BackgroundGlucose-6-phosphate dehydrogenase (G6PD) deficiency remains a significant global health burden, particularly in malaria-endemic regions. Despite advances in diagnostic capabilities and treatment strategies, the prevalence and associated disability burden continue to evolve. This study prov...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhengyu Yu, Qiang Xiong, Zhongwang Wang, Linfeng Li, Ting Niu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2025.1593728/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849715089333026816
author Zhengyu Yu
Qiang Xiong
Zhongwang Wang
Linfeng Li
Ting Niu
author_facet Zhengyu Yu
Qiang Xiong
Zhongwang Wang
Linfeng Li
Ting Niu
author_sort Zhengyu Yu
collection DOAJ
description BackgroundGlucose-6-phosphate dehydrogenase (G6PD) deficiency remains a significant global health burden, particularly in malaria-endemic regions. Despite advances in diagnostic capabilities and treatment strategies, the prevalence and associated disability burden continue to evolve. This study provides a comprehensive assessment of the global, regional, and national burden of G6PD deficiency from 1990 to 2021, using the Global Burden of Disease (GBD) 2021 database.MethodsData were retrieved from GBD 2021, covering 204 countries and territories. Prevalence, incidence, and years lived with disability (YLDs) were analyzed. Age-standardized rates (ASRs) and estimated annual percentage change (EAPC) were computed to assess trends over time. The relationship between socio-demographic index (SDI) and G6PD burden was examined using Spearman correlation analysis.ResultsIn 2021, global prevalence reached 443,326,869 cases, an 80.17% increase from 1990. The highest burden was observed in South Asia, accounting for 138,159,940 cases. The largest percentage increase in prevalence was in Andean Latin America (+291.96%). G6PD deficiency burden was negatively correlated with SDI, but high SDI regions exhibited higher prevalence than expected. Age- and sex-specific analysis revealed a higher burden in males, particularly in childhood and older age groups.ConclusionThis study underscores the growing burden of G6PD deficiency, with substantial regional disparities. The findings emphasize the need for improved screening programs, policy interventions, and resource allocation in low- and middle-income countries (LMICs). Continued surveillance is essential to mitigate the long-term health consequences of this disorder.
format Article
id doaj-art-dd435f72bd7e4bb5b2f2fb2d909e1e0e
institution DOAJ
issn 1664-8021
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj-art-dd435f72bd7e4bb5b2f2fb2d909e1e0e2025-08-20T03:13:30ZengFrontiers Media S.A.Frontiers in Genetics1664-80212025-05-011610.3389/fgene.2025.15937281593728Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021Zhengyu Yu0Qiang Xiong1Zhongwang Wang2Linfeng Li3Ting Niu4Department of Hematology, West China Hospital, Sichuan University, Chengdu, ChinaNational Center for Occupational Safety and Health, National Health Commission of the People’s Republic of China, Beijing, ChinaDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Hematology, West China Hospital, Sichuan University, Chengdu, ChinaBackgroundGlucose-6-phosphate dehydrogenase (G6PD) deficiency remains a significant global health burden, particularly in malaria-endemic regions. Despite advances in diagnostic capabilities and treatment strategies, the prevalence and associated disability burden continue to evolve. This study provides a comprehensive assessment of the global, regional, and national burden of G6PD deficiency from 1990 to 2021, using the Global Burden of Disease (GBD) 2021 database.MethodsData were retrieved from GBD 2021, covering 204 countries and territories. Prevalence, incidence, and years lived with disability (YLDs) were analyzed. Age-standardized rates (ASRs) and estimated annual percentage change (EAPC) were computed to assess trends over time. The relationship between socio-demographic index (SDI) and G6PD burden was examined using Spearman correlation analysis.ResultsIn 2021, global prevalence reached 443,326,869 cases, an 80.17% increase from 1990. The highest burden was observed in South Asia, accounting for 138,159,940 cases. The largest percentage increase in prevalence was in Andean Latin America (+291.96%). G6PD deficiency burden was negatively correlated with SDI, but high SDI regions exhibited higher prevalence than expected. Age- and sex-specific analysis revealed a higher burden in males, particularly in childhood and older age groups.ConclusionThis study underscores the growing burden of G6PD deficiency, with substantial regional disparities. The findings emphasize the need for improved screening programs, policy interventions, and resource allocation in low- and middle-income countries (LMICs). Continued surveillance is essential to mitigate the long-term health consequences of this disorder.https://www.frontiersin.org/articles/10.3389/fgene.2025.1593728/fullglucose 6-phosphate dehydrogenase deficiencyglobal burden of diseaseprevalenceyears lived with disabilityepidemiology
spellingShingle Zhengyu Yu
Qiang Xiong
Zhongwang Wang
Linfeng Li
Ting Niu
Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
Frontiers in Genetics
glucose 6-phosphate dehydrogenase deficiency
global burden of disease
prevalence
years lived with disability
epidemiology
title Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
title_full Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
title_fullStr Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
title_full_unstemmed Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
title_short Global, regional, and national burden of glucose-6-phosphate dehydrogenase (G6PD) deficiency from 1990 to 2021: a systematic analysis of the global burden of disease study 2021
title_sort global regional and national burden of glucose 6 phosphate dehydrogenase g6pd deficiency from 1990 to 2021 a systematic analysis of the global burden of disease study 2021
topic glucose 6-phosphate dehydrogenase deficiency
global burden of disease
prevalence
years lived with disability
epidemiology
url https://www.frontiersin.org/articles/10.3389/fgene.2025.1593728/full
work_keys_str_mv AT zhengyuyu globalregionalandnationalburdenofglucose6phosphatedehydrogenaseg6pddeficiencyfrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021
AT qiangxiong globalregionalandnationalburdenofglucose6phosphatedehydrogenaseg6pddeficiencyfrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021
AT zhongwangwang globalregionalandnationalburdenofglucose6phosphatedehydrogenaseg6pddeficiencyfrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021
AT linfengli globalregionalandnationalburdenofglucose6phosphatedehydrogenaseg6pddeficiencyfrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021
AT tingniu globalregionalandnationalburdenofglucose6phosphatedehydrogenaseg6pddeficiencyfrom1990to2021asystematicanalysisoftheglobalburdenofdiseasestudy2021